Incidence of Invasive fungal infections 30th day after the end of first line chemotherapy [clinicaltrials_resource:7576f3cb448cc1fff0f93535fbc2ead3]
To identify possible fungal infections sources for the period preceding the diagnosis of leukemia, in particular those related to normal activities of daily life (e.g. occupation, location and type of residence, consume of tobacco, alcohol or illicit drugs and others).
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Incidence of Invasive fungal infections 30th day after the end of first line chemotherapy [clinicaltrials_resource:7576f3cb448cc1fff0f93535fbc2ead3]
To identify possible fungal infections sources for the period preceding the diagnosis of leukemia, in particular those related to normal activities of daily life (e.g. occupation, location and type of residence, consume of tobacco, alcohol or illicit drugs and others).
Bio2RDF identifier
7576f3cb448cc1fff0f93535fbc2ead3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7576f3cb448cc1fff0f93535fbc2ead3
measure [clinicaltrials_vocabulary:measure]
Incidence of Invasive fungal infections
time frame [clinicaltrials_vocabulary:time-frame]
30th day after the end of first line chemotherapy
description
To identify possible fungal in ...... or illicit drugs and others).
identifier
clinicaltrials_resource:7576f3cb448cc1fff0f93535fbc2ead3
title
Incidence of Invasive fungal infections 30th day after the end of first line chemotherapy
@en
type
label
Incidence of Invasive fungal i ...... 6f3cb448cc1fff0f93535fbc2ead3]
@en